Actively Recruiting
Impact of Ambulatory Continuous Monitoring Using Remote Monitoring Medicine Within Patient's Care Pathway Following Colorectal Surgery - A Multicenter Randomized Study
Led by Nantes University Hospital · Updated on 2026-03-19
362
Participants Needed
14
Research Sites
N/A
Total Duration
On this page
Sponsors
N
Nantes University Hospital
Lead Sponsor
E
EPOCA U&I
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the impact of using a remote monitoring platform to support patients after colorectal surgery who are at risk of being readmitted to the hospital. The study compares the effectiveness of 30 days of remote monitoring after discharge versus the conventional discharge process. The goal is to see if the remote monitoring can reduce hospital readmission and improve recovery in patients who have undergone colorectal surgery. Participants are randomly assigned to one of two groups: one group receives usual care with a conventional discharge and follow-up visits, while the other group uses the remote monitoring platform for 30 days after leaving the hospital. The remote platform connects patients and healthcare professionals through devices like oximeters, blood pressure monitors, and other tools to track health status. Both groups have a routine postoperative visit at 30 days and a follow-up phone call at 90 days. Patients also keep a diary of healthcare use during the 90 days. During the study, participants will attend standard postoperative assessments and complete questionnaires on quality of life and satisfaction. Researchers will monitor hospital readmissions, complications, recovery milestones such as return of bowel function, and overall healthcare use over 90 days. The study includes interviews and focus groups with patients and healthcare providers to gather qualitative feedback. Safety and medical-economic outcomes will also be evaluated throughout the 90-day follow-up period.
CONDITIONS
Brief Title
Impact of Ambulatory Continuous Monitoring Using Remote Monitoring Medicine Within Patient's Care Pathway Following Colorectal Surgery (CONTACT-GRECCAR 21)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Man or woman over 18 years old at the time of the J0 visit
- Patient who underwent colorectal surgery less than 28 days ago or is scheduled to undergo colorectal surgery not managed as an outpatient procedure
- Underwent resection of at least one colonic or rectal segment and/or an anastomosis involving the colon or rectum
- Meets at least one of these: anticipated early discharge (within 24 hours after laparoscopic surgery without stoma, or within 5 days after laparotomy and/or surgery with stoma and/or rectal surgery), or estimated risk of hospital readmission greater than 10% according to the specified score
- Patient affiliated with a health insurance plan
- Patient who has signed the study consent form
You will not qualify if you...
- Discharge to a rehabilitation center requested by the patient
- Condition managed on an outpatient basis in routine practice
- Patient eligible for home hospitalization services
- Suicidal or hetero-aggressive risk in a patient living alone at home
- Homeless patient
- Pregnant or breastfeeding women
- Patient under legal guardianship, curatorship, or protected legal status
- Patient already enrolled in an interventional postoperative follow-up study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day 0
Participants undergo colorectal surgery as part of their treatment.
1 visit (in-person)
Duration - 30 days after hospital discharge
Participants are monitored after hospital discharge either through standard care or a remote monitoring platform for 30 days to track recovery and health status.
1 routine postoperative consultation visit on Day 30 and phone contact on Day 90
Duration - 90 days after hospital discharge
Participants complete a patient diary from Day 0 to Day 90 to record healthcare utilization and are contacted by phone at Day 90 for final follow-up.
1 phone contact on Day 90
Trial Site Locations
Total: 14 locations
1
CHU Angers
Angers, France
Actively Recruiting
2
Clinique Tivoli- Ducos
Bordeaux, France
Actively Recruiting
3
CHU Grenoble
Grenoble, France
Actively Recruiting
4
Centre Hospitalier Lyon-Sud
Lyon, France
Actively Recruiting
5
CHU Timone - Assistance publique-Hôpitaux de Marseille
Marseille, France
Actively Recruiting
6
Hôpital Nord - Assistance publique- Hôpitaux de Marseille
Marseille, France
Actively Recruiting
7
Institut Paoli Calmettes
Marseille, France
Not Yet Recruiting
8
CHU Nantes
Nantes, France
Actively Recruiting
9
Hôpital de Bicêtre - Assistance Publique Hôpitaux de Paris
Paris, France
Actively Recruiting
10
Hôpital Saint Antoine - Assistance publique - Hôpitaux de Paris
Paris, France
Actively Recruiting
11
CHU Rennes
Rennes, France
Actively Recruiting
12
Clinique Mutualiste de l'estuaire
Saint-Nazaire, France
Actively Recruiting
13
CHU Toulouse
Toulouse, France
Actively Recruiting
14
CHRU Tours
Tours, France
Actively Recruiting
Research Team
E
Emilie DUCHALAIS
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here